Propensity score‐matched comparison of docetaxel and androgen receptor axis‐targeted agents in patients with castration‐resistant intraductal carcinoma of the prostate
Sign Up to like & getrecommendations! Published in 2019 at "BJU International"
DOI: 10.1111/bju.14970
Abstract: To evaluate the efficacy of docetaxel and androgen receptor axis‐targeted (ARAT) agents in patients with castration‐resistant prostate cancer (CRPC) with intraductal carcinoma of the prostate (IDC‐P) using a propensity score‐matched analysis. read more here.
Keywords: prostate; docetaxel androgen; receptor axis; axis targeted ... See more keywords